Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Warner

Showing results (401-410 of 435) with videos related to

Pageof 44
Sort By:
Hepatology (Baltimore, Md.)|July 7, 2025
Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|January 27, 2026
ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|April 15, 2024
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid CrisisMarkus Ammann, Michelle A O Kinney, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 12, 2018
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary AssociationJohn C Mansour, Kenneth Chavin, Gareth Morris-Stiff, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
The Oncologist|September 2, 2025
Outcomes of Palliative Porto-Mesenteric Venous Stenting in Unresectable Pancreatic MalignanciesStella Konadu Adjei Antwi, Andrea Zironda, Alessandro Fogliati, et al.
Pageof 44

Showing results (401-410 of 435) with videos related to

Sort By:
Pageof 44
Hepatology (Baltimore, Md.)|July 7, 2025
Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|January 27, 2026
ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|April 15, 2024
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid CrisisMarkus Ammann, Michelle A O Kinney, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 12, 2018
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary AssociationJohn C Mansour, Kenneth Chavin, Gareth Morris-Stiff, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
The Oncologist|September 2, 2025
Outcomes of Palliative Porto-Mesenteric Venous Stenting in Unresectable Pancreatic MalignanciesStella Konadu Adjei Antwi, Andrea Zironda, Alessandro Fogliati, et al.
Pageof 44